Therapy-related myeloid leukemia
- PMID: 8707757
- DOI: 10.1016/s0889-8588(05)70340-3
Therapy-related myeloid leukemia
Abstract
One of the most serious possible consequences of cancer therapy is the development of a second cancer, especially leukemia. Several distinct subsets of therapy-related leukemia can be distinguished currently. These include classic therapy-related myeloid leukemia, leukemia that follows treatment with agents that inhibit topoisomerase II, acute lymphoblastic leukemia, and leukemias with 21q22 rearrangements or inv(16) or t(15;17). These types of leukemia are discussed in detail in this article.
Similar articles
-
Myeloid leukemia after hematotoxins.Environ Health Perspect. 1996 Dec;104 Suppl 6(Suppl 6):1303-7. doi: 10.1289/ehp.961041303. Environ Health Perspect. 1996. PMID: 9118910 Free PMC article. Review.
-
Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma.Leuk Lymphoma. 1996 Feb;20(5-6):365-72. doi: 10.3109/10428199609052417. Leuk Lymphoma. 1996. PMID: 8833391 Review.
-
Therapy-related acute leukemia.Clin Lab Med. 2000 Mar;20(1):71-81, ix. Clin Lab Med. 2000. PMID: 10702897 Review.
-
Secondary leukaemia after autologous bone marrow transplantation.Lancet. 1995 Apr 1;345(8953):810. doi: 10.1016/s0140-6736(95)92960-6. Lancet. 1995. PMID: 7898226 No abstract available.
-
[Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].Med Klin (Munich). 2004 Sep 15;99(9):506-17. doi: 10.1007/s00063-004-1077-7. Med Klin (Munich). 2004. PMID: 15372180 Review. German.
Cited by
-
Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10984-9. doi: 10.1073/pnas.190167297. Proc Natl Acad Sci U S A. 2000. PMID: 10995463 Free PMC article.
-
Canadian supportive care recommendations for the management of neutropenia in patients with cancer.Curr Oncol. 2008 Jan;15(1):9-23. doi: 10.3747/co.2008.198. Curr Oncol. 2008. PMID: 18317581 Free PMC article.
-
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.J Clin Oncol. 2013 Feb 10;31(5):592-8. doi: 10.1200/JCO.2012.44.5791. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295809 Free PMC article.
-
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.Br J Pharmacol. 2011 Feb;162(4):792-805. doi: 10.1111/j.1476-5381.2010.01100.x. Br J Pharmacol. 2011. PMID: 21039422 Free PMC article. Review.
-
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.Br J Cancer. 2000 Jul;83(1):91-4. doi: 10.1054/bjoc.2000.1196. Br J Cancer. 2000. PMID: 10883674 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical